However, another study has shown significant anti-tumour activity of osimertinib in xenograft models of the WT EGFR lung cancer cell line H2073 cells engineered to express either D770_N771insSVD or V769_D770InsASV insertions using CRISPR [53]. This evidence concerns the gene EGFR and neoplasm.